Verona Pharma plc buy Wolfe Research
Start price
01.07.25
/
50%
€0.51
Target price
01.07.26
€144.28
Performance (%)
-
End price
02.07.26
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Verona Pharma plc | - | - | - |
| iShares Core DAX® | -1,11 % | 0,20 % | 1,21 % |
| iShares Nasdaq 100 | -4,35 % | -3,25 % | 25,87 % |
| iShares Nikkei 225® | -6,79 % | -7,72 % | 50,97 % |
| iShares S&P 500 | -1,79 % | 0,99 % | 21,07 % |
Comments by Wolfe_Research for this prediction
In the thread Verona Pharma plc diskutieren
Verona Pharma PLC American Depositary Share (NASDAQ: VRNA) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $170.00 price target on the stock.
Ratings data for VRNA provided by MarketBeat
In the thread Trading Verona Pharma plc
Die von Wolfe_Research gewählte maximale Laufzeit wurde überschritten